Catherine Skari

TIF Presents The Federation’s Annual Report For 2020

“Our commitment to unite the patient voice and to advocate at the highest possible levels for equal access to all…

Read More »

CDC, FDA Authorize Third Dose Of COVID-19 Vaccines For The Immunocompromised In The US

The U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC)  have both recommended…

Read More »

TIF e-Academy: Reimagining Thalassaemia and Sickle Cell Disease Education

Read. Learn. Empower. The Thalassaemia International Federation´s internationally acclaimed Educational Programme is a fundamental component of TIF´s work and is…

Read More »

NEW EVENT | Register Now For The 1st PIBA Members’ Meeting!

Watch the Full PIBA Meeting Video Recording HERE.

Read More »

Global Blood Submits US Application For Expanded Use Of SCD Drug, Oxbryta, In Patients Aged 4-11 Years

Children with sickle cell disease (SCD) as young as age 4 could be prescribed Oxbryta (Voxelotor) if the U.S. Food and Drug Administration…

Read More »

World Hepatitis Day 2021: Hep Can’t Wait!

July 28 marks World Hepatitis Day 2021. World Hepatitis Day (WHD) is observed every year on 28 July to raise…

Read More »

TIF Newsletter – July 2021

Read More »

Hemoglobin Disorders In Europe: A Systematic Effort Of Identifying And Addressing Unmet Needs And Challenges By TIF

The recent population movement has led to a steady increase of carriers and patients with haemoglobin disorders, namely thalassaemia and…

Read More »

WORLD BLOOD DONOR DAY 2022 | Donating Blood Is An Act Of Solidarity

Read More »

Bluebird Bio Resumes Marketing Of Gene Therapy Zynteglo For β-Thalassaemia In Europe

The European Medicines Agency (EMA)’s safety committee (PRAC) has concluded that there is no evidence Zynteglo causes a blood cancer…

Read More »